These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29572796)

  • 21. Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma.
    Hasegawa Y; Goto M; Hanai N; Ijichi K; Terada A; Hyodo I; Ogawa T; Fukushima M
    Oncology; 2007; 73(1-2):104-11. PubMed ID: 18337622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The measurement of glucose consumption in histoculture to determine effects of doxorubicin and cisplatinum on human gastric carcinoma.
    Chang SG; Chai SE; Kim ES; Yoon C; Joo HZ; Hoffman RM
    Anticancer Res; 1993; 13(5A):1303-10. PubMed ID: 8239500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.
    Caponigro F; Rosati G; De Rosa P; Avallone A; De Rosa V; De Lucia L; Comella P; Comella G
    Oncology; 2002; 63(3):232-8. PubMed ID: 12381902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity to cisplatin determined by the histoculture drug response assay and clinical response of endometrial cancer.
    Kanasugi M; Aoki D; Suzuki N; Susumu N; Nakata S; Horiuchi M; Udagawa Y; Nozawa S
    Int J Gynecol Cancer; 2006; 16(1):409-15. PubMed ID: 16445667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Histoculture drug response assay on non-small cell lung cancer].
    Yoshimasu T; Oura S; Maebeya S; Tanino H; Bessho T; Arimoto J; Sakurai T; Matsuyama K; Naito Y; Furukawa T; Yano T; Suzuma T; Hirai I
    Gan To Kagaku Ryoho; 2000 May; 27(5):717-22. PubMed ID: 10832440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Significance of the Histoculture Drug Response Assay in Breast Cancer.
    Shinden Y; Kijima Y; Hirata M; Arima H; Nakajyo A; Tanoue K; Maemura K; Natsugoe S
    Anticancer Res; 2016 Nov; 36(11):6173-6178. PubMed ID: 27793948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemosensitivity of breast cancer lymph node metastasis compared to the primary tumor from individual patients tested in the histoculture drug response assay.
    Furukawa T; Kubota T; Tanino H; Oura S; Yuasa S; Murate H; Morita K; Kozakai K; Yano T; Hoffman RM
    Anticancer Res; 2000; 20(5C):3657-8. PubMed ID: 11268434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial between two neoadjuvant chemotherapy protocols: CDDP + 5-FU versus CDDP + VP16 in advanced cancer of the head and neck.
    Prévost A; Mérol JC; Aimé P; Moutel K; Roger-Liautaud F; Nasca S; Legros M; Coninx P
    Oncol Rep; 2005 Sep; 14(3):771-6. PubMed ID: 16077990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer.
    De Andrés L; Brunet J; López-Pousa A; Burgués J; Vega M; Tabernero JM; Mesía R; López JJ
    J Clin Oncol; 1995 Jun; 13(6):1493-500. PubMed ID: 7751897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histoculture drug response assay to monitor chemoresponse.
    Ohie S; Udagawa Y; Aoki D; Nozawa S
    Methods Mol Med; 2005; 110():79-86. PubMed ID: 15901929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applicability of histoculture drug response assays in colorectal cancer chemotherapy.
    Yoon YS; Kim CW; Roh SA; Cho DH; Kim GP; Hong YS; Kim TW; Kim MB; Kim JC
    Anticancer Res; 2012 Aug; 32(8):3581-6. PubMed ID: 22843949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The identification of candidate effective combination regimens for pancreatic cancer using the histoculture drug response assay.
    Jun E; Park Y; Lee W; Kwon J; Lee S; Kim MB; Lee JS; Song KB; Hwang DW; Lee JH; Hoffman RM; Kim SC
    Sci Rep; 2020 Jul; 10(1):12004. PubMed ID: 32686712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting 5-FU sensitivity using human colorectal cancer specimens: comparison of tumor dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activities with in vitro chemosensitivity to 5-FU.
    Isshi K; Sakuyama T; Gen T; Nakamura Y; Kuroda T; Katuyama T; Maekawa Y
    Int J Clin Oncol; 2002 Dec; 7(6):335-42. PubMed ID: 12494248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting nedaplatin sensitivity of cervical cancer using the histoculture drug response assay.
    Kato R; Hasegawa K; Achiwa Y; Okamoto H; Torii Y; Oe S; Udagawa Y
    Eur J Gynaecol Oncol; 2011; 32(4):381-6. PubMed ID: 21941957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histoculture drug response assay, a possible examination system for predicting the antitumor effect of aromatase inhibitors in patients with breast cancer.
    Nakamura J; Imai E; Yoshihama M; Sasano H; Kubota T
    Anticancer Res; 1998; 18(1A):125-8. PubMed ID: 9568066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Low-dose CDDP and 5-FU for head and neck cancer patients].
    Fujii M; Kanke M; Tomita T
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1542-7. PubMed ID: 10553410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Induction chemotherapy based on histoculture drug response assay for a patient with advanced thymic cancer--a case report].
    Tanino H; Miyoshi S; Furukawa T; Bessho T; Maebeya S; Suzuma T; Hirai I; Arimoto J; Harada N; Hoso T; Naito Y
    Gan To Kagaku Ryoho; 1997 May; 24(7):861-4. PubMed ID: 9170526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy for malignant gliomas based on histoculture drug response assay : a pilot study.
    Gwak HS; Park HJ; Yoo H; Youn SM; Rhee CH; Lee SH
    J Korean Neurosurg Soc; 2011 Nov; 50(5):426-33. PubMed ID: 22259689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Head and neck cancer].
    Inuyama Y; Fukuda S; Fujii M; Tanaka K; Kawaura M; Kawasaki K; Kohno N
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1136-42. PubMed ID: 8751800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of the histoculture drug response assay (HDRA) based perioperative chemotherapy for non-small cell lung cancer].
    Tanahashi M; Yamada T; Moriyama S; Suzuki E; Niwa H
    Kyobu Geka; 2008 Jan; 61(1):26-30. PubMed ID: 18186269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.